Response to PI3K/mTOR dual inhibition in Glioma initiating cells
Ontology highlight
ABSTRACT: The PI3K/mammalian target of rapamycin (mTOR) pathway is dysregulated in over 50% of human GBM but remains a challenging clinical target. Inhibitors against PI3K/mTOR mediators have limited clinical efficacy as single agents. Gene expression profiling after PI3K/mTOR inhibition treatment was analyzed by Affymetrix microarrays.
ORGANISM(S): Homo sapiens
PROVIDER: GSE79316 | GEO | 2016/05/20
SECONDARY ACCESSION(S): PRJNA315450
REPOSITORIES: GEO
ACCESS DATA